Rare diseases
Investigational molecules
Locations
Back to Croatia85 clinical trials in Osijek, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
CroatiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CroatiaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
CroatiaStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
CroatiaA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
CroatiaCroatiaA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
CroatiaA study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes
CroatiaStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
CroatiaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
CroatiaStudy on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema
CroatiaStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for psoriatic arthritis, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new therapeutic approaches targeting specific immune pathways.
Investigations include both biologic and non-biologic treatment options for patients with varying disease severity.
Comprehensive studies examining treatments for Crohn's Disease and Ulcerative Colitis. Research focuses on novel therapeutic compounds and combination treatments.
Trials aim to improve clinical outcomes and quality of life for patients with moderate to severe disease.
Advanced research into Multiple Sclerosis and tardive dyskinesia treatments. Studies evaluate new therapeutic approaches and compare treatment efficacy.
Focus on developing treatments that can slow disease progression and improve symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
